Package 27241-183-30

{"route": ["ORAL"], "spl_id": "9791ac5c-7be4-4ff8-8de3-21ab21346ca9", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0327241184307", "0327241186301", "0327241183300", "0327241185304"], "unii": ["U3H27498KS"], "rxcui": ["103968", "198430", "252478", "252479"], "spl_set_id": ["9dfb5f87-0150-4c26-a89f-34f1ab389500"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (27241-183-30)", "package_ndc": "27241-183-30", "marketing_start_date": "20210119"}], "brand_name": "Lamotrigine", "product_id": "27241-183_9791ac5c-7be4-4ff8-8de3-21ab21346ca9", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "27241-183", "generic_name": "Lamotrigine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA213271", "marketing_category": "ANDA", "marketing_start_date": "20210119", "listing_expiration_date": "20261231"}